Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Johnson & Johnson Hit with $500 Million Verdict in Trial over Hip Implants

Jessica Dye  |  March 17, 2016

NEW YORK (Reuters)—Johnson & Johnson and its DePuy unit were ordered by a Texas federal jury on Thursday to pay a total of about $500 million to five plaintiffs who said they were injured by Pinnacle metal-on-metal hip implants.

Following a two-month trial, jurors found that the Pinnacle hips were defectively designed, and that the companies failed to warn the public about their risks.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Jurors awarded about $130 million in total compensatory damages and about $360 million in punitive damages, according to the plaintiffs’ lead trial lawyer, Mark Lanier.

“There are thousands of these cases, and J&J needs to get responsible,” Lanier said following the verdict, which came in the second federal trial involving the Pinnacle device.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

J&J was cleared of liability in the first trial ended in 2014.

A J&J spokeswoman said the company plans to appeal the verdict.

All five plaintiffs are Texas residents who were implanted with metal-on-metal Pinnacle hip devices. They said design flaws caused the devices to fail more frequently and quickly than expected, leading to injuries, including tissue death, bone erosion and high levels of metal in their blood.

Share: 

Filed under:Uncategorized Tagged with:hiphip replacementimplantJohnson & JohnsonlawsuitLegal

Related Articles

    Verdict: Johnson & Johnson to Pay More Than $1 Billion for Defective Hip Implants

    December 4, 2016

    (Reuters)—A federal jury in Dallas on Thursday ordered Johnson & Johnson (J&J) and its DePuy Orthopaedics unit to pay more than $1 billion to six plaintiffs who said they were injured by Pinnacle hip implants. The jurors found that the metal-on-metal Pinnacle hip implants were defectively designed and that the companies failed to warn consumers…

    U.S. Judge Cuts $500 Million Verdict over Johnson & Johnson Hip Implants

    July 6, 2016

    NEW YORK (Reuters)—A U.S. judge has slashed a $500 million verdict against Johnson and Johnson and its DePuy unit over allegedly defective metal-on-metal Pinnacle hip implants to approximately $151 million. On Tuesday, U.S. District Judge Ed Kinkeade in the Northern District of Texas says he was compelled to reduce the verdict under a Texas state…

    Cobalt Toxicity Complication of Hip Replacement Surgery

    September 1, 2014

    Rheumalogists urged to recognize toxicity symptoms in patients with metal-on-metal or metal-on-polyethylene hip implants

    Hip-Resurfacing Arthroplasty an Alternative to Total Hip Replacement

    December 1, 2014

    Resurfacing procedure preserves bone, lasts longer, allows patients higher level of functionality

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences